Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials

Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials

Abstract Introduction Fingolimod has demonstrated clinical and MRI benefits versus placebo/interferon β-1a in young adults with multiple sclerosis (MS). Here we report the long-term effects of fingolimod 0.5 mg on clinical and MRI outcomes in young adults with MS aged ≤ 30 years followed up for up t...

Full description

Bibliographic Details
Main Authors: Angelo Ghezzi, Tanuja Chitnis, Annik K-Laflamme, Rolf Meinert, Dieter A. Häring, Daniela Pohl
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-07-01
Series:Neurology and Therapy
Subjects:
Disability
Fingolimod
Multiple sclerosis
Relapse rates
Young adults
Online Access:http://link.springer.com/article/10.1007/s40120-019-0146-z

Internet

http://link.springer.com/article/10.1007/s40120-019-0146-z

Similar Items